Speaker illustration

Doctor Efstratios Apostolou

LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

Heart Failure Association

Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries.

Event: ESC Congress 2022

Topic: Lipids

Session: Lipids 2


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb